- £8.65m
- £9.85m
- £21.71m
- 78
- 78
- 25
- 66
2019 September 30th | 2020 September 30th | R2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 19.5 | 20.7 | 18.3 | 19.3 | 21.7 |
Cost of Revenue | |||||
Gross Profit | 4.36 | 4.69 | 3.71 | 4.4 | 5.07 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 19.7 | 20.1 | 18.6 | 18.2 | 21 |
Operating Profit | -0.202 | 0.616 | -0.348 | 1.08 | 0.707 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.237 | 0.551 | -0.387 | 1.07 | 0.759 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.052 | 0.595 | -0.022 | 1.19 | 0.859 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.052 | 0.595 | -0.022 | 1.19 | 0.859 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.052 | 0.595 | -0.022 | 1.19 | 0.859 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.017 | 0.053 | -0.013 | 0.024 | 0.026 |
Dividends per Share |